Abilify sustained release aqueous suspension intramuscular injection 400mg, from Otsuka Pharmaceutical (YJ code: 1179410E2023, standard: 400mg x 1 bottle with suspension liquid), contains Aripiprazole hydrate. This atypical antipsychotic is indicated for conditions like schizophrenia, bipolar I disorder, and as an adjunctive treatment for major depressive disorder.
Abilify sustained release aqueous suspension intramuscular injection 400mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →